Analyst Expectations For Albemarle's Future
21 analysts have shared their evaluations of Albemarle (NYSE:ALB) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 6 | 4 | 11 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 2 | 1 | 4 | 0 | 0 |
| 2M Ago | 3 | 2 | 4 | 0 | 0 |
| 3M Ago | 1 | 1 | 2 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $174.52, along with a high estimate of $230.00 and a low estimate of $113.00. Witnessing a positive shift, the current average has risen by 37.27% from the previous average price target of $127.14.
Interpreting Analyst Ratings: A Closer Look
The analysis of recent analyst actions sheds light on the perception of Albemarle by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Patrick Cunningham | Citigroup | Raises | Neutral | $190.00 | $180.00 |
| John Roberts | Mizuho | Raises | Neutral | $185.00 | $156.00 |
| Jeffrey Zekauskas | JP Morgan | Raises | Neutral | $195.00 | $80.00 |
| Laurence Alexander | Jefferies | Raises | Buy | $230.00 | $210.00 |
| Michael Sison | Wells Fargo | Raises | Equal-Weight | $174.00 | $135.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $180.00 | $150.00 |
| Colin Rusch | Oppenheimer | Raises | Outperform | $207.00 | $109.00 |
| Peter Osterland | Truist Securities | Raises | Buy | $205.00 | $125.00 |
| Corinne Blanchard | Deutsche Bank | Raises | Buy | $185.00 | $125.00 |
| Joshua Spector | UBS | Raises | Buy | $205.00 | $185.00 |
| John Roberts | Mizuho | Raises | Neutral | $156.00 | $132.00 |
| Ben Isaacson | Scotiabank | Raises | Sector Outperform | $200.00 | $85.00 |
| Ben Kallo | Baird | Raises | Outperform | $210.00 | $113.00 |
| Laurence Alexander | Jefferies | Raises | Buy | $167.00 | $152.00 |
| Michael Sison | Wells Fargo | Raises | Equal-Weight | $135.00 | $100.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $150.00 | $100.00 |
| John Roberts | Mizuho | Raises | Neutral | $132.00 | $110.00 |
| Joshua Spector | UBS | Raises | Buy | $185.00 | $107.00 |
| Corinne Blanchard | Deutsche Bank | Raises | Hold | $125.00 | $110.00 |
| Ben Kallo | Baird | Raises | Neutral | $113.00 | $81.00 |
| Joel Jackson | BMO Capital | Raises | Outperform | $136.00 | $125.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Albemarle. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Albemarle compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Albemarle's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Albemarle's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Albemarle analyst ratings.
Delving into Albemarle's Background
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
Albemarle: A Financial Overview
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Negative Revenue Trend: Examining Albemarle's financials over 3M reveals challenges. As of 30 September, 2025, the company experienced a decline of approximately -3.46% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Albemarle's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -15.47%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Albemarle's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -2.57%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Albemarle's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -1.18%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.48.
Analyst Ratings: Simplified
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.